STOCK TITAN

Vita Coco COO sells 16,827 shares under plan

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth exercised non-qualified stock options for 16,827 shares of common stock at $10.1780 per share on September 17, 2025, then sold the same 16,827 shares at a weighted average price of $42.5460 under a Rule 10b5-1 trading plan, with sales between $42.50 and $42.73. Following these transactions, he directly holds 76,127 shares of common stock and 426,265 non-qualified stock options.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Officer exercised vested options and sold the same shares under a 10b5-1 plan; transaction appears compliant and routine.

The filing shows an exercise of vested non-qualified stock options and contemporaneous sales executed under a documented Rule 10b5-1 trading plan. This pattern is common for executives realizing compensation value while following pre-established trading instructions, which reduces insider ownership but demonstrates procedural compliance. The disclosure of the weighted-average sale price range and undertaking to provide per-price details supports transparency.

TL;DR: Executive monetized option spread, capturing a significant per-share gain; impact on capitalization is immaterial to operations.

The reporting officer exercised options at $10.178 and sold at a weighted average of $42.546, realizing the option spread on 16,827 shares. The reported post-transaction direct holdings fell to 76,127 shares. The filing also enumerates additional option grants and vesting schedules that could create future share dilution if exercised, but no information on hedging or large secondary transactions beyond the 10b5-1 sale is provided.

Insider Burth Jonathan
Role Chief Operating Officer
Sold 16,827 shs ($716K)
Approx. gross sale proceeds $716K
Approx. exercise cost $171K
Approx. pre-tax spread $545K
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) 16,827 $0.00 $0.00
Exercise Common Stock 16,827 $10.178 $171K
Sale Common Stock 16,827 $42.546 $716K
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 426,265 contracts for 394,267 underlying shares (Direct); Common Stock — 76,127 shares (Direct)
Footnotes (10)
  1. F1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.73, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3. The stock option is fully vested and currently exercisable.
  4. F4. The stock option is fully vested and currently exercisable.
  5. F5. The stock option is fully vested and currently exercisable.
  6. F6. The stock option vests in four equal annual installments beginning on November 27, 2022.
  7. F7. The stock option vests in three equal annual installments beginning on August 15, 2025.
  8. F8. The stock option vests in four equal annual installments beginning on March 10, 2024.
  9. F9. The stock option vests in four equal annual installments beginning on March 4, 2025.
  10. F10. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Options Exercised 16,827 shares Non-qualified stock options exercised at $10.1780 per share on September 17, 2025
Shares Sold 16,827 shares Common stock sold at a weighted average price of $42.5460 per share on September 17, 2025
Weighted Average Sale Price $42.5460 per share Sales executed in multiple transactions between $42.50 and $42.73 under a Rule 10b5-1 plan
Post-transaction Common Stock 76,127 shares Direct common stock holdings after the reported transactions
Post-transaction Stock Options 426,265 options Direct non-qualified stock options outstanding following the transactions
Option Exercise Price $10.1780 per share Exercise price of the non-qualified stock options converted into 16,827 common shares
Non-Qualified Stock Option financial
"security_title "Non-Qualified Stock Option (right to buy)""
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Rule 10b5-1 trading plan regulatory
"The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
underlying security financial
"underlying_security_title "Common Stock" and underlying_security_shares"
vests in four equal annual installments financial
"The stock option vests in four equal annual installments beginning on March 4, 2025"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Vita Coco (COCO) report for its COO?

Vita Coco COO Jonathan Burth exercised 16,827 stock options at $10.1780 per share and sold the resulting 16,827 common shares at a $42.5460 weighted average price on September 17, 2025 under a Rule 10b5-1 trading plan.

How many Vita Coco (COCO) shares did the COO sell, and at what price?

Jonathan Burth sold 16,827 shares of Vita Coco common stock at a $42.5460 weighted average price, with trades executed between $42.50 and $42.73 per share, pursuant to a pre-arranged Rule 10b5-1 trading plan.

What are Jonathan Burth’s remaining Vita Coco (COCO) holdings after this Form 4?

After these transactions, Jonathan Burth directly holds 76,127 shares of Vita Coco common stock and 426,265 non-qualified stock options, as reported in the filing’s canonical post-transaction holdings summary.

Were the Vita Coco (COCO) COO’s share sales made under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected under a Rule 10b5-1 trading plan, meaning they followed a pre-established schedule. The sales used a weighted average price with executions between $42.50 and $42.73 per share.

What option terms are highlighted for Vita Coco (COCO) COO Jonathan Burth?

The exercised options covered 16,827 shares at a $10.1780 exercise price. Additional non-qualified stock options remain outstanding, with various exercise prices and expirations through 2035, and some grants described as fully vested and currently exercisable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Burth Jonathan

(Last) (First) (Middle)
250 PARK AVE SOUTH
SEVENTH FLOOR

(Street)
NEW YORK NY 10003

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/17/2025 M 16,827 A $10.178 92,954 D
Common Stock 09/17/2025 S(1) 16,827 D $42.546(2) 76,127 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $10.178 09/17/2025 M 16,827 (3) 12/16/2029 Common Stock 16,827 $0.0 31,998 D
Non-Qualified Stock Option (right to buy) $10.178 (4) 02/10/2030 Common Stock 222,950 222,950 D
Non-Qualified Stock Option (right to buy) $10.178 (5) 01/11/2031 Common Stock 34,125 34,125 D
Non-Qualified Stock Option (right to buy) $15 (6) 10/21/2031 Common Stock 58,043 58,043 D
Non-Qualified Stock Option (right to buy) $15.36 (7) 08/15/2032 Common Stock 42,980 42,980 D
Non-Qualified Stock Option (right to buy) $16.91 (8) 03/10/2033 Common Stock 14,205 14,205 D
Non-Qualified Stock Option (right to buy) $26.18 (9) 03/04/2034 Common Stock 8,746 8,746 D
Non-Qualified Stock Option (right to buy) $33.36 (10) 03/04/2035 Common Stock 13,218 13,218 D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.73, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. The stock option is fully vested and currently exercisable.
4. The stock option is fully vested and currently exercisable.
5. The stock option is fully vested and currently exercisable.
6. The stock option vests in four equal annual installments beginning on November 27, 2022.
7. The stock option vests in three equal annual installments beginning on August 15, 2025.
8. The stock option vests in four equal annual installments beginning on March 10, 2024.
9. The stock option vests in four equal annual installments beginning on March 4, 2025.
10. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
By: Alison Klein, Attorney-in-Fact For: Jonathan Burth 09/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Keep reading